ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SPH Sinclair Pha

31.80
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Sinclair Pha LSE:SPH London Ordinary Share GB0033856740 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 31.80 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Sinclair Pharma PLC Holding(s) in Company (8839M)

18/10/2016 5:55pm

UK Regulatory


TIDMSPH

RNS Number : 8839M

Sinclair Pharma PLC

18 October 2016

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                          Sinclair Pharma Plc 
  the underlying issuer                                                   Sedol 3385674 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------  -------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
--------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
------------------------------------------------------------  ------------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------  ------------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------  ------------------------------------- 
 An event changing the breakdown of voting rights                               X 
------------------------------------------------------------  ------------------------------------- 
 Other (please 
  specify): 
----------------------------------------------------------    ------------------------------------- 
 3. Full name of person(s)                                    (1) Lansdowne Partners International 
  subject to the                                               Limited 
  notification obligation:                                     (2) Lansdowne Partners Limited 
  (iii)                                                        (3) Lansdowne Partners (UK) 
                                                               LLP 
-----------------------------------------------------------  -------------------------------------- 
 4. Full name of shareholder(s)                               HSBC Client Holdings Nominee 
  (if different from 3.):(iv)                                  (UK) Ltd 
 
                                                               (Registered Shareholder) 
-----------------------------------------------------------  -------------------------------------- 
 5. Date of the transaction                                   30/09/2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  -------------------------------------- 
 6. Date on which issuer                                      18/10/2016 
  notified: 
-----------------------------------------------------------  -------------------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                          12% 
-----------------------------------------------------------  -------------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                   Resulting situation after the 
  of             to the triggering                    triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  -----------------------------------  ------------------------------------------------------------------ 
                Number            Number             Number          Number of                % of voting 
                 of                of                 of shares       voting                   rights (x) 
                 Shares            Voting                             rights 
                                   Rights 
-------------  ----------------  -----------------  --------------  -----------------------  ------------------------- 
                                                     Direct          Direct     Indirect      Direct        Indirect 
                                                                     (xi)        (xii) 
-------------      ------------    -------------    --------------  ---------  ------------  ------------  ----------- 
   Ordinary 
    Shares      59,987,523        59,987,523                                    59,987,523                  11.95% 
               ----------------  -----------------  --------------  ---------  ------------  ------------  ----------- 
 GB0033856740 
-------------      ------------    -------------      ------------    -------  ------------      --------    --------- 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration      Exercise/                          Number of voting           % of voting 
 financial           date            Conversion                         rights that                rights 
 instrument          (xiii)          Period (xiv)                       may be 
                                                                        acquired if 
                                                                        the 
                                                                        instrument 
                                                                        is 
                                                                        exercised/ 
                                                                        converted. 
-----------------  --------------  ---------------------------------  -------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise        Expiration       Exercise/         Number of voting           % of voting 
 financial         price          date             Conversion         rights instrument          rights (xix, 
 instrument                       (xvii)           period             refers to                  xx) 
                                                   (xviii) 
---------------  --------------  ---------------  ----------------  -------------------------  ----------------------- 
                                                                                                Nominal       Delta 
---------------  --------------  ---------------  ----------------  -------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                               Percentage of voting rights 
----------------------------------------------------  ---------------------------------------------------------------- 
 59,987,523                                            11.95% 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
---------------------------------------------------------------------------------------------- 
 Lansdowne Partners International Limited is the parent 
  undertaking of Lansdowne Partners Limited which is the 
  First Corporate Member of Lansdowne Partners (UK) LLP 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------  ------------------------------- 
 11. Number of voting rights proxy 
  holder will cease to hold: 
-------------------------------------------------------------  ------------------------------- 
 12. Date on which proxy holder will 
  cease to hold voting rights: 
-------------------------------------------------------------  ------------------------------- 
 
 
  13. Additional information:                                    Based on total voting rights 
                                                                 of 502,089,508 
-------------------------------------------------------------  ------------------------------- 
 14. Contact name:                                              Ruari Paton 
-------------------------------------------------------------  ------------------------------- 
 15. Contact telephone number:                                  +44 020 7290 5500 
-------------------------------------------------------------  ------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLMPBFTMBIBBRF

(END) Dow Jones Newswires

October 18, 2016 12:55 ET (16:55 GMT)

1 Year Sinclair Pharma Chart

1 Year Sinclair Pharma Chart

1 Month Sinclair Pharma Chart

1 Month Sinclair Pharma Chart

Your Recent History

Delayed Upgrade Clock